Prairie View Partners, LLC Cor Medix Inc. Call Options Transaction History
Prairie View Partners, LLC
- $958 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CRMD
# of Institutions
142Shares Held
23.1MCall Options Held
442KPut Options Held
574K-
Vanguard Group Inc Valley Forge, PA3.65MShares$38.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$37.5 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl2.87MShares$30.3 Million0.14% of portfolio
-
State Street Corp Boston, MA1.45MShares$15.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.43MShares$15.1 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $435M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...